1
|
Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy.
|
Clin Infect Dis
|
2004
|
4.26
|
2
|
Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria.
|
Nat Immunol
|
2011
|
3.48
|
3
|
Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.
|
Arch Intern Med
|
2002
|
2.20
|
4
|
Unmasked tuberculosis and tuberculosis immune reconstitution inflammatory disease: a disease spectrum after initiation of antiretroviral therapy.
|
J Infect Dis
|
2009
|
2.04
|
5
|
Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina.
|
AIDS
|
2009
|
1.81
|
6
|
Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis.
|
J Infect Dis
|
2006
|
1.80
|
7
|
Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study.
|
PLoS One
|
2008
|
1.56
|
8
|
Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
|
Clin Infect Dis
|
2010
|
1.54
|
9
|
The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode.
|
J Exp Med
|
2010
|
1.50
|
10
|
Late presenters in an HIV surveillance system in Italy during the period 1992-2006.
|
J Acquir Immune Defic Syndr
|
2008
|
1.47
|
11
|
Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure.
|
AIDS Res Hum Retroviruses
|
2002
|
1.45
|
12
|
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014.
|
New Microbiol
|
2015
|
1.45
|
13
|
Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study.
|
Respir Res
|
2007
|
1.45
|
14
|
Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis.
|
EMBO J
|
2011
|
1.43
|
15
|
Upregulation of interferon-induced genes in infants with virus-associated acute bronchiolitis.
|
Exp Biol Med (Maywood)
|
2007
|
1.42
|
16
|
Epidemiology of viral hepatitis infections in an area of southern Italy with high incidence rates of liver cancer.
|
Eur J Cancer
|
2008
|
1.33
|
17
|
Late presenters in new HIV diagnoses from an Italian cohort of HIV-infected patients: prevalence and clinical outcome.
|
Antivir Ther
|
2011
|
1.30
|
18
|
Conformational changes in IgE contribute to its uniquely slow dissociation rate from receptor FcɛRI.
|
Nat Struct Mol Biol
|
2011
|
1.29
|
19
|
Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay.
|
Clin Diagn Lab Immunol
|
2005
|
1.29
|
20
|
Extensively drug-resistant tuberculosis, Italy and Germany.
|
Emerg Infect Dis
|
2007
|
1.29
|
21
|
Definition and epidemiology of late presentation in Europe.
|
Antivir Ther
|
2010
|
1.23
|
22
|
Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.
|
Am J Respir Crit Care Med
|
2014
|
1.22
|
23
|
Cutting edge: structural basis for the recognition of β-linked glycolipid antigens by invariant NKT cells.
|
J Immunol
|
2011
|
1.20
|
24
|
The effect of age on response to therapy with peginterferon alpha plus ribavirin in a cohort of patients with chronic HCV hepatitis including subjects older than 65 yr.
|
Am J Gastroenterol
|
2007
|
1.20
|
25
|
Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?
|
PLoS One
|
2010
|
1.18
|
26
|
IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy.
|
BMC Infect Dis
|
2011
|
1.12
|
27
|
Soluble CD23 monomers inhibit and oligomers stimulate IGE synthesis in human B cells.
|
J Biol Chem
|
2007
|
1.12
|
28
|
IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis.
|
J Infect
|
2013
|
1.10
|
29
|
HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin.
|
J Hepatol
|
2004
|
1.08
|
30
|
Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition.
|
Clin Infect Dis
|
2011
|
1.07
|
31
|
Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosis.
|
Mol Med
|
2003
|
1.06
|
32
|
Glycolipids that elicit IFN-γ-biased responses from natural killer T cells.
|
Chem Biol
|
2011
|
1.05
|
33
|
New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response.
|
BMC Infect Dis
|
2009
|
1.05
|
34
|
IP-10 detection in urine is associated with lung diseases.
|
BMC Infect Dis
|
2010
|
1.05
|
35
|
IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis.
|
J Infect
|
2010
|
1.04
|
36
|
NKT cell ligand recognition logic: molecular basis for a synaptic duet and transmission of inflammatory effectors.
|
J Immunol
|
2011
|
1.04
|
37
|
Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
|
Clin Infect Dis
|
2005
|
1.04
|
38
|
Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study.
|
BMC Infect Dis
|
2008
|
1.03
|
39
|
Simple and reliable method for detection and genotyping of hepatitis C virus RNA in dried blood spots stored at room temperature.
|
J Clin Microbiol
|
2002
|
1.01
|
40
|
Effective highly active antiretroviral therapy in patients with primary HIV-1 infection prevents the evolution of the avidity of HIV-1-specific antibodies.
|
J Acquir Immune Defic Syndr
|
2007
|
1.01
|
41
|
Behavioral correlates of adherence to antiretroviral therapy.
|
J Acquir Immune Defic Syndr
|
2002
|
1.01
|
42
|
Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders.
|
PLoS One
|
2011
|
1.01
|
43
|
Implications of storing urinary DNA from different populations for molecular analyses.
|
PLoS One
|
2009
|
1.00
|
44
|
Detection of Pulmonary tuberculosis: comparing MR imaging with HRCT.
|
BMC Infect Dis
|
2011
|
1.00
|
45
|
Tuberculosis transmission between foreign- and native-born populations in the EU/EEA: a systematic review.
|
Eur Respir J
|
2013
|
0.98
|
46
|
Structural basis for the recognition of C20:2-αGalCer by the invariant natural killer T cell receptor-like antibody L363.
|
J Biol Chem
|
2011
|
0.97
|
47
|
How many people are living with undiagnosed HIV infection? An estimate for Italy, based on surveillance data.
|
AIDS
|
2016
|
0.97
|
48
|
Risk of tuberculosis following HIV seroconversion in high-income countries.
|
Thorax
|
2012
|
0.96
|
49
|
Specific T cells restore the autophagic flux inhibited by Mycobacterium tuberculosis in human primary macrophages.
|
J Infect Dis
|
2012
|
0.96
|
50
|
Comparison of LCx with other current viral load assays for detecting and quantifying human immunodeficiency virus type 1 RNA in patients infected with the circulating recombinant form A/G (CRF02).
|
J Clin Microbiol
|
2004
|
0.96
|
51
|
Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02).
|
J Acquir Immune Defic Syndr
|
2002
|
0.96
|
52
|
Access to antiretroviral treatment, incidence of sustained therapy interruptions, and risk of clinical events according to sex: evidence from the I.Co.N.A. Study.
|
J Acquir Immune Defic Syndr
|
2003
|
0.95
|
53
|
Impact of hepatitis C virus infection on lifestyle.
|
World J Gastroenterol
|
2007
|
0.95
|
54
|
Higher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood.
|
PLoS One
|
2011
|
0.95
|
55
|
IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country.
|
J Infect
|
2012
|
0.93
|
56
|
Expression levels of TLRs involved in viral recognition in PBMCs from HIV-1-infected patients failing antiretroviral therapy.
|
Intervirology
|
2009
|
0.92
|
57
|
Structure of the uncomplexed Neisseria meningitidis factor H-binding protein fHbp (rLP2086).
|
Acta Crystallogr Sect F Struct Biol Cryst Commun
|
2011
|
0.92
|
58
|
Hepatitis E virus genotype 4 outbreak, Italy, 2011.
|
Emerg Infect Dis
|
2013
|
0.92
|
59
|
Monophyletic HIV type 1 CRF02-AG in a nosocomial outbreak in Benghazi, Libya.
|
AIDS Res Hum Retroviruses
|
2002
|
0.92
|
60
|
Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
|
Clin Infect Dis
|
2008
|
0.92
|
61
|
Monophyletic outbreak of Hepatitis A involving HIV-infected men who have sex with men, Rome, Italy 2008-2009.
|
J Clin Virol
|
2012
|
0.92
|
62
|
Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs.
|
BMC Infect Dis
|
2009
|
0.92
|
63
|
Gene expression of nucleic acid-sensing pattern recognition receptors in children hospitalized for respiratory syncytial virus-associated acute bronchiolitis.
|
Clin Vaccine Immunol
|
2009
|
0.91
|
64
|
A toolbox for tuberculosis diagnosis: an Indian multicentric study (2006-2008): microbiological results.
|
PLoS One
|
2012
|
0.90
|
65
|
HIV incidence estimate combining HIV/AIDS surveillance, testing history information and HIV test to identify recent infections in Lazio, Italy.
|
BMC Infect Dis
|
2012
|
0.90
|
66
|
Serial QuantiFERON TB-gold in-tube testing during LTBI therapy in candidates for TNFi treatment.
|
J Infect
|
2012
|
0.89
|
67
|
A toolbox for tuberculosis (TB) diagnosis: an Indian multicentric study (2006-2008). Evaluation of QuantiFERON-TB gold in tube for TB diagnosis.
|
PLoS One
|
2013
|
0.89
|
68
|
Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals.
|
Antivir Ther
|
2005
|
0.89
|
69
|
Helicobacter pylori cholesteryl α-glucosides contribute to its pathogenicity and immune response by natural killer T cells.
|
PLoS One
|
2013
|
0.88
|
70
|
The potential impact of routine testing of individuals with HIV indicator diseases in order to prevent late HIV diagnosis.
|
BMC Infect Dis
|
2013
|
0.88
|
71
|
T cell responses to commercial mycobacterium tuberculosis-specific antigens in HIV-infected patients.
|
Clin Infect Dis
|
2007
|
0.87
|
72
|
Atomic structure of the autosomal recessive hypercholesterolemia phosphotyrosine-binding domain in complex with the LDL-receptor tail.
|
Proc Natl Acad Sci U S A
|
2012
|
0.86
|
73
|
Structural and functional characterization of a novel nonglycosidic type I NKT agonist with immunomodulatory properties.
|
J Immunol
|
2012
|
0.86
|
74
|
'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing.
|
J Antimicrob Chemother
|
2011
|
0.85
|
75
|
Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy.
|
Antivir Ther
|
2006
|
0.84
|
76
|
Consent policies and rates of HIV testing.
|
JAMA
|
2007
|
0.84
|
77
|
Strengthening tuberculosis diagnosis in a low-resource setting: experience learned in Dodoma, Tanzania.
|
J Infect Dev Ctries
|
2013
|
0.84
|
78
|
HIV-Infected Late Presenter Patients.
|
AIDS Res Treat
|
2011
|
0.83
|
79
|
Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe.
|
Eur Respir J
|
2013
|
0.83
|
80
|
Tuberculosis case finding based on symptom screening among immigrants, refugees and asylum seekers in Rome.
|
BMC Public Health
|
2013
|
0.83
|
81
|
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013.
|
J Acquir Immune Defic Syndr
|
2014
|
0.82
|
82
|
Characteristics and behaviors in a sample of patients unaware of their infection until AIDS diagnosis in Italy: a cross-sectional study.
|
AIDS Care
|
2011
|
0.82
|
83
|
Retrospective investigation of an influenza A/H1N1pdm outbreak in an Italian military ship cruising in the Mediterranean Sea, May-September 2009.
|
PLoS One
|
2011
|
0.82
|
84
|
Epidemiological aspects of major opportunistic infections of the respiratory tract in persons with AIDS: Europe, 1993-2000.
|
AIDS
|
2003
|
0.82
|
85
|
Cystic echinococcosis in a single tertiary care center in Rome, Italy.
|
Biomed Res Int
|
2013
|
0.81
|
86
|
HIV-1 DNA burden dynamics in CD4 T cells and monocytes in patients undergoing a transient therapy interruption.
|
J Med Virol
|
2004
|
0.81
|
87
|
Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patients.
|
AIDS
|
2005
|
0.81
|
88
|
Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy.
|
BMC Infect Dis
|
2009
|
0.81
|
89
|
Human neutrophil peptides stimulate tumor necrosis factor-alpha release by alveolar macrophages from patients with sarcoidosis.
|
Chest
|
2009
|
0.81
|
90
|
Pharmacodynamics of interferon beta in multiple sclerosis patients with or without serum neutralizing antibodies.
|
J Neurol
|
2007
|
0.80
|
91
|
Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation.
|
Antivir Ther
|
2003
|
0.80
|
92
|
Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimen.
|
J Antimicrob Chemother
|
2013
|
0.78
|
93
|
Improvement of tuberculosis laboratory capacity on Pemba Island, Zanzibar: a health cooperation project.
|
PLoS One
|
2012
|
0.78
|
94
|
[Time trends in infectious disease mortality in Italy: 1969-1999].
|
Epidemiol Prev
|
2005
|
0.78
|
95
|
Possible child-to-mother transmission of HIV by breastfeeding.
|
JAMA
|
2005
|
0.77
|
96
|
Age and prediction of sustained virological response to hepatitis C virus (HCV) infection treatment based on 28-day decrease in HCV RNA levels.
|
J Infect Dis
|
2009
|
0.77
|
97
|
Chronic hepatitis C in Italy: the vanishing of the first and most consistent epidemic wave.
|
Dig Liver Dis
|
2013
|
0.77
|
98
|
Cavitary pulmonary tuberculosis HIV-related.
|
Eur J Radiol
|
2004
|
0.77
|
99
|
Triple therapy for hepatitis C improves viral response but also increases the risk of severe infections and anaemia: a frequentist meta-analysis approach.
|
New Microbiol
|
2014
|
0.76
|
100
|
The combination of a smoking cessation programme with rehabilitation increases stop-smoking rate.
|
J Rehabil Med
|
2008
|
0.76
|
101
|
Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy.
|
BMC Res Notes
|
2013
|
0.75
|
102
|
Should individuals who are tuberculin skin test negative and positive to RD1-IFN-gamma assay receive preventive therapy?
|
Am J Respir Crit Care Med
|
2007
|
0.75
|
103
|
Effect of hepatitis C virus genotype on CD4+ T cell count in a cohort of antiretroviral-naive HIV-1-infected individuals.
|
J Infect Dis
|
2005
|
0.75
|
104
|
Percentage and determinants of missed HIV testing in pregnancy: a survey of women delivering in the Lazio region, Italy.
|
AIDS Care
|
2013
|
0.75
|
105
|
Temporal trend and characteristics of recent HIV-1 infections: application of an algorithm for the identification of recently acquired HIV-1 infections among newly diagnosed individuals over a 10-year period.
|
New Microbiol
|
2013
|
0.75
|
106
|
Partnership of HIV-infected women and health status.
|
J Acquir Immune Defic Syndr
|
2005
|
0.75
|
107
|
HIV self-testing in Italy.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|
108
|
The 2005 Italian Quality Control Study for the evaluation of CD4 cells in centers involved in the treatment of HIV type 1 patients.
|
AIDS Res Hum Retroviruses
|
2007
|
0.75
|
109
|
Drop in CD4+ counts below 200 cells/µL after reaching (or starting from) values higher than 350 cells/µL in HIV-infected patients with virological suppression.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|
110
|
Corrigendum: NANS-mediated synthesis of sialic acid is required for brain and skeletal development.
|
Nat Genet
|
2017
|
0.75
|